Profound Medical Corp. (PROF) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Profound Medical Corp. (PROF)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

7.27

-0.18 (-2.42%)

At close: Jan 14, 2025, 3:59 PM

7.30

0.44%

After-hours Jan 14, 2025, 04:00 PM EST

undefined% (undefined)

Bid	5.99
Market Cap	218.24M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1.34
PE Ratio (ttm)	-5.42
Forward PE	n/a
Analyst	Strong Buy

Ask	9.73
Volume	106,326
Avg. Volume (20D)	69,614
Open	7.52
Previous Close	7.45
Day's Range	7.07 - 7.60
52-Week Range	6.78 - 11.42
Beta	undefined

About PROF

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sona...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Oct 29, 2019

Employees 131

Stock Exchange NASDAQ

Ticker Symbol PROF

Website https://www.profoundmedical.com

Analyst Forecast

According to 2 analyst ratings, the average rating for PROF stock is "Strong Buy." The 12-month stock price forecast is $11.4, which is an increase of 56.86% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Profound Medical Corp. is scheduled to release its earnings on Mar 6, 2025, during market hours.
Analysts project revenue of $5.92M, reflecting a 196.00% YoY growth and earnings per share of -0.34, making a -19.05% decrease YoY.

Why Price Moved

6 months ago · Source

+6.01%

Profound Medical shares are trading higher after S... Unlock content with Pro Subscription

News

1 week ago · zacks.com

Does Profound Medical (PROF) Have the Potential to Rally 100.13% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 100.1% in Profound Medical (PROF). While the effectiveness of this highly sought-after metric is questionable, ...

2 months ago · seekingalpha.com

Profound Medical Corporation (PROF) Q3 2024 Earnings Call Transcript

Profound Medical Corporation (NASDAQ:PROF ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Stephen Kilmer - IR Arun Menawat - CEO Rashed Dewan - CFO Mathieu Burtnyk ...

2 months ago · zacks.com

Profound Medical (PROF) Reports Q3 Loss, Lags Revenue Estimates

Profound Medical (PROF) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.26 per share a year ago.

2 months ago · zacks.com

Wall Street Analysts Predict a 106.45% Upside in Profound Medical (PROF): Here's What You Should Know

The consensus price target hints at a 106.5% upside potential for Profound Medical (PROF). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...